Gregor Obernosterer is currently a Strategic Portfolio Lead at RoX Health, where they focus on innovation in remote patient monitoring and digital pathology. They previously held various roles at Roche, including Strategic Partnerships and Oncology Innovation Manager, managing sequencing solutions and enhancing collaborations within the healthcare ecosystem. Prior to Roche, Gregor co-founded CSO Lanifex Software Development & Consulting GmbH and worked as a Postdoctoral Fellow at both the Netherlands Cancer Institute and the Whitehead Institute. Gregor studied at IE Business School from 2016 to 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices